Positive Result for SARS-CoV-2 RNA Test after a Long Time for the Patient with COVID-19 even after Discharge from the Hospital
Novelty in Biomedicine,
Vol. 9 No. 3 (2021),
13 Mordad 2021
,
Page 152-155
https://doi.org/10.22037/nbm.v9i3.35376
Abstract
Background: Ruthin's coronavirus disease 2019 (COVID-19) diagnosis is based on the positive result of real-time polymerase chain reaction (PCR) from the nasal and oropharyngeal swab. However, chest CT scans can play an important role in diagnosing patients with COVID-19.Cases Report: In this study, we reported a 44 years old female with a mild form of the COVID-19 who showed a positive result for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA for 44 days after symptom onset. The suspected case was detected using real-time PCR. After two weeks of hospitalization, the patient was discharged, but her molecular tests were performed twice after one month and 44 days, and they remained positive for SARS-CoV-2 RNA.
Conclusion: In theory, if the patient becomes re-infected or the virus reacts, these individuals may serve as a transmission source. So far, the only way to screen for possible reinfection has been by using PCR on separate specimens.
- COVID-19, Real-time polymerase chain reaction, Patient outcome assessment
How to Cite
References
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020;395(10223):497-506.
Wei Q, Wang Y, Ma J, Han J, Jiang M, Zhao L, et al. Description of the First Strain of 2019-nCoV, C-Tan-nCoV Wuhan Strain—National Pathogen Resource Center, China, 2020. 2020;2(6):81-2.
Update WJM, . http://www. who. int/esr/sarsarchive/-05-07a/en. 49-SARS case fatality ratio, incubation period. 2020.
Zumla A, Niederman MSJCoipm. The explosive epidemic outbreak of novel coronavirus disease 2019 (COVID-19) and the persistent threat of respiratory tract infectious diseases to global health security. 2020.
Wang C, Horby PW, Hayden FG, Gao GFJTl. A novel coronavirus outbreak of global health concern. 2020;395(10223):470-3.
Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, et al. Epidemiology, transmission dynamics and control of SARS: the 2002–2003 epidemic. 2004;359(1447):1091-105.
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. 2020;92(7):797-806.
van Kampen JJ, van de Vijver DA, Fraaij PL, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). 2021;12(1):1-6.
Stöhr KJTL. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. 2003;361(9370):1730-3.
Yam W, Chan K, Poon L, Guan Y, Yuen K, Seto W, et al. Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus. 2003;41(10):4521-4.
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. 2020;25(3):2000045.
Tahamtan A, Ardebili AJEromd. Real-time RT-PCR in COVID-19 detection: issues affecting the results. 2020;20(5):453-4.
He X, Lau EH, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. 2020;26(5):672-5.
Kujawski SA, Wong KK, Collins JP, Epstein L, Killerby ME, Midgley CM, et al. First 12 patients with coronavirus disease 2019 (COVID-19) in the United States. 2020.
Wolfel R, Corman V, Guggemos WJN. Virological assessment of hospitalized cases of coronavirus disease. 2020;581:465-9.
Beeching NJ, Fletcher TE, Beadsworth MB. Covid-19: testing times. British Medical Journal Publishing Group; 2020.
Corse T, Dayan L, Kersten S, Battaglia F, Terlecky SR, Han ZJIjoms. Clinical Outcomes of COVID-19 Patients with Pre-existing, Compromised Immune Systems: A Review of Case Reports. 2020;17(18):2974.
Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. 2020;8(5):475-81.
Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. 2020;7(6):998-1002.
Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam AJJoI, Health P. Immune response in COVID-19: A review. 2020.
Rasmussen AL, Popescu SVJS. SARS-CoV-2 transmission without symptoms. 2021;371(6535):1206-7.
To KK-W, Hung IF-N, Ip JD, Chu AW-H, Chan W-M, Tam AR, et al. COVID-19 reinfection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. 2020.
Zhou X, Zhou J, Zhao JJBid. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report. 2020;20(1):1-4.
Alonso FO, Sabino BD, Guimarães MA, Varella RBJJomv. Recurrence of SARS‐CoV‐2 infection with a more severe case after mild COVID‐19, reversion of RT‐qPCR for positive and late antibody response: Case report. 2021;93(2):655-6.
Zhang L, Richards A, Barrasa MI, Hughes SH, Young RA, Jaenisch RJPotNAoS. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. 2021;118(21).
Kang Y-JJDM, Preparedness PH. South Korea's COVID-19 infection status: from the perspective of re-positive test results after viral clearance evidenced by negative test results. 2020:1-3.
- Abstract Viewed: 156 times
- pdf Downloaded: 123 times